Bone Biologics Corp (BBLG) Stock Analysis

Bone Biologics Corp (BBLG) is a publicly traded company in the HEALTHCARE sector. It trades at $1.25, carries a market capitalization of $2.30M. This page summarizes the public market data, fundamentals, and frequently asked questions for BBLG, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $1.25
• Market Cap: $2.30M
• EPS: $-1.16
• 52-Week High: $6.75
• 52-Week Low: $1.05

Market Sentiment

Bone Biologics Corp currently has a Bullish sentiment score of 0.35.

About Bone Biologics Corp

Bone Biologics Corp (BBLG) is an innovative medical device company focused on revolutionizing bone regeneration technologies, particularly in the spinal fusion sector. Utilizing proprietary recombinant human protein formulations, BBLG aims to enhance surgical outcomes and expedite patient recovery through its advanced regenerative solutions. Based in Burlington, Massachusetts, the company is strategically positioned to address critical clinical needs within orthopedics and spinal surgery, cat...

GNG Research Analysis

GNG Research scores Bone Biologics Corp (BBLG) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for BBLG.

Frequently Asked Questions

Does BBLG pay dividends?

Bone Biologics Corp (BBLG) does not currently pay a regular dividend.

What is BBLG's market cap?

Bone Biologics Corp (BBLG) has a market capitalization of $2.30M with a current stock price of $1.25.